Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.52 (market cap $8.47B), while Vanguard Intermediate Term Corporate Bond ETF trades at $78.85 (market cap $72.20B). The key difference: Vanguard Intermediate Term Corporate Bond ETF is far larger — about 8.5× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Vanguard Intermediate Term Corporate Bond ETF for 64 Days on average.
| HNGE | VCIT | |
|---|---|---|
Market Cap | $8.47B | $72.20B |
Volume | 1,624,526 | 13,245,117 |
Sector | Health | Fixed Income |
52-Week High | $105.14 | $84.82 |
52-Week Low | $31.17 | $77.98 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $8.09B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
VCIT, the Vanguard Intermediate-Term Corporate Bond ETF, trades at $78.48, down 0.03% on the day. The technical outlook is mixed with a bullish overall signal but bearish moving averages, while fundamentals are supported by a 4.8% yield and low 0.03% expense ratio. Recent news highlights institutional buying and favorable comparisons to peer bond ETFs.
The outlook for VCIT is positive for income-focused investors seeking corporate bond exposure with low costs. Key opportunities include attractive yield and institutional interest, while risks involve interest rate sensitivity and credit spread volatility in the corporate bond market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →
